Opioids in COVID-19: Two Sides of a Coin.  Palamim CVC, Boschiero MN, Faria AG, Valencise FE, Marson FAL.  Front Pharmacol. 2022 Jan 6;12:758637. doi: 10.3389/fphar.2021.758637. PMID: 35069193; PMCID: PMC8770909. https://www.ncbi.nlm.ni…

How has the COVID-19 epidemic affected the risk behaviors of people who inject drugs in a city with high harm reduction service coverage in Vietnam? A qualitative investigation.  Nguyen TT, Hoang GT, Nguyen DQ, Nguyen AH, Luong NA, Laureillard…

No party, no drugs? Use of stimulants, dissociative drugs, and GHB/GBL during the early COVID-19 pandemic.  Bendau A, Viohl L, Petzold MB, Helbig J, Reiche S, Marek R, Romanello A, Moon DU, Gross RE, Masah DJ, Gutwinski S, Mick I, Montag C, Ev…

Could COVID expand the future of addiction research? Long-term implications in the pandemic era. Englund, A, Sharman, S, Tas, B, Strang, J. Addiction. 2022; 1– 6. doi.org/10.1111/add.15790 https://onlinelibrary.wiley…

COVID-19-Pandemie: E-Health-Interventionen verbessern die psychische Gesundheit Lethbridge (Kanada) – Die COVID-19-Pandemie hat weltweit auch negative Auswirkungen auf die psy­chische Gesundheit. Vor diesem Hintergrund untersuchten kanadische Forsc…

Worldwide wastewater analysis reveals rise of designer drugs during lockdowns Chemical analysis of sewage in 10 countries over Christmas and new year 2020–21 has shown how new psychoactive substances have spread across the world. One designer drug…